The application of molecular modelling in the safety assessment of chemicals: A case study on ligand-dependent PPARγ dysregulation

Toxicology
Merilin Al SharifMark T Cronin

Abstract

The aim of this paper was to provide a proof of concept demonstrating that molecular modelling methodologies can be employed as a part of an integrated strategy to support toxicity prediction consistent with the mode of action/adverse outcome pathway (MoA/AOP) framework. To illustrate the role of molecular modelling in predictive toxicology, a case study was undertaken in which molecular modelling methodologies were employed to predict the activation of the peroxisome proliferator-activated nuclear receptor γ (PPARγ) as a potential molecular initiating event (MIE) for liver steatosis. A stepwise procedure combining different in silico approaches (virtual screening based on docking and pharmacophore filtering, and molecular field analysis) was developed to screen for PPARγ full agonists and to predict their transactivation activity (EC50). The performance metrics of the classification model to predict PPARγ full agonists were balanced accuracy=81%, sensitivity=85% and specificity=76%. The 3D QSAR model developed to predict EC50 of PPARγ full agonists had the following statistical parameters: q2cv=0.610, Nopt=7, SEPcv=0.505, r2pr=0.552. To support the linkage of PPARγ agonism predictions to prosteatotic potential, molecular model...Continue Reading

References

Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Nov 8, 2001·Proceedings of the National Academy of Sciences of the United States of America·H E XuT M Willson
Dec 18, 2004·Bioorganic & Medicinal Chemistry Letters·John J ActonHarold B Wood
Feb 17, 2005·Bioorganic & Medicinal Chemistry Letters·Per SauerbergIngrid Pettersson
Nov 23, 2005·Bioorganic & Medicinal Chemistry Letters·Ying LuFengming Chu
Jun 2, 2006·Bioorganic & Medicinal Chemistry Letters·Bernd KuhnPeter Mohr
Oct 13, 2006·Journal of Medicinal Chemistry·Neeraj MahindrooHsing-Pang Hsieh
Feb 13, 2007·Bioorganic & Medicinal Chemistry Letters·Pratik V DevasthalePeter T W Cheng
May 8, 2007·European Journal of Medicinal Chemistry·Anshuman Dixit, Anil K Saxena
Oct 17, 2007·Structure·John B BruningPatrick R Griffin
Mar 7, 2008·European Journal of Medicinal Chemistry·Palak ShahPrasad V Bharatam
May 2, 2008·European Journal of Medicinal Chemistry·Sandeep Sundriyal, Prasad V Bharatam
May 13, 2008·Environmental Health Perspectives·James R RabinowitzMelissa A Pasquinelli
Feb 10, 2009·Bioorganic & Medicinal Chemistry Letters·Hao ZhangPeter T W Cheng
Feb 12, 2009·Molecular Diversity·Georgia MelagrakiOlga Igglessi-Markopoulou
Apr 8, 2009·Bioorganic & Medicinal Chemistry Letters·Agnes BénardeauPeter Mohr
Sep 29, 2009·Bioorganic & Medicinal Chemistry·Agustin Casimiro-GarciaKun Song
Jan 12, 2010·Human & Experimental Toxicology·Robert F Phalen
Jan 12, 2010·Human & Experimental Toxicology·William J Waddell
Jun 25, 2010·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Daniel KrewskiLauren Zeise
Apr 13, 2011·European Journal of Medicinal Chemistry·Belal O Al-NajjarMutasem O Taha
Apr 17, 2012·Journal of Molecular Graphics & Modelling·Laura GuaschSantiago Garcia-Vallvé
Jun 22, 2012·Journal of Medicinal Chemistry·Michael M MysingerBrian K Shoichet
Feb 25, 2015·Regulatory Toxicology and Pharmacology : RTP·Grace PatlewiczRichard A Becker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.